EUVIMEDEUVIMED entdecken
Delphi-StudieOpen Access · CC BY 4.0

Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus

Juan Alban, R Christopher Bowen iD, David A Reichstein, Meredith McKean, Jose Lutzky, Ezekiel Weis, Richard D Carvajal, Susan Dulka, Brian G Morse iD, Marcus O Butler iD, Suthee Rapisuwon, Kevin B Kim und 38 weitere

Cancers · 30.12.2025 · 18 (1) · 121

DOI: 10.3390/cancers18010121 ↗

Kurz gefasst

Delphi-Studie in der Zeitschrift Cancers, online erschienen am 30.12.2025. Verfasst von Juan Alban und 49 weiteren Autor:innen. Beteiligte Einrichtung: Robert H. Lurie Comprehensive Cancer Center, Division of Hematology Oncology, Northwestern University, Chicago, IL 60616, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Uveal melanoma is a rare but aggressive intraocular malignancy that metastasizes in up to half of patients, most commonly to the liver, despite effective local treatment. In the absence of robust evidence, there are no standardized guidelines for post-treatment surveillance, resulting in wide variation in imaging modalities, frequency, and duration across physicians and institutions. This study aimed to develop expert consensus recommendations for surveillance strategies in patients with uveal melanoma.

Methods

A modified Delphi method was conducted across three iterative survey rounds between September 2024 and February 2025 using an online platform. Panelists included medical oncologists, ocular oncologists, radiologists, and surgical oncologists from North America. A multidisciplinary steering committee developed statements addressing risk-based surveillance using both molecular and clinical prognostic factors, including gene expression profiling (GEP) and PRAME status. Consensus was defined a priori as ≥70% of panelists rating a statement 7–9 on a 9-point Likert scale.

Results

Forty-nine experts were invited, and 41 completed at least one survey round. The panel represented 17 U.S. states, Washington, D.C., and two Canadian provinces. Twelve statements reached stable consensus, including recommendations for imaging modality, frequency, and duration in intermediate- and high-risk patients. Although there was agreement that low-risk patients warrant surveillance, no consensus was reached on the optimal approach for this group.

Conclusions

This is the first study to provide consensus-based guidance incorporating GEP and PRAME status into surveillance recommendations for uveal melanoma, offering a standardized framework to guide clinical practice and future research.

Schlagwörter

Stichwörter der Autor:innen

PRAMEgene-expression profilemetastatic uveal melanoma surveillanceuveal melanoma

Autor:innen und Institutionen

  • Robert H. Lurie Comprehensive Cancer Center, Division of Hematology Oncology, Northwestern University, Chicago, IL 60616, USA.
  • Department of Ophthalmology, Northwestern University, Chicago, IL 60616, USA.
  • Tennessee Retina, Nashville, TN 37203, USA.
  • Sarah Cannon Research Institute, Nashville, TN 37203, USA.
  • Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA.
  • Department of Ophthalmology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T5H 3V9, Canada.

ORCID-Profile: R Christopher Bowen, Brian G Morse, Marcus O Butler, Allison Betof Warner, Jonathan S Zager, Bartosz Chmielowski, Zelia M Correa, Kamaneh Montazeri, Alexander N Shoushtari, Dan S Gombos, April K S Salama, Evan J Lipson, Shailender Bhatia, Inderjit Mehmi, Alexandra P Ikeguchi, Scott D Walter, Arun D Singh, Namita Gandhi, J William Harbour, Sunandana Chandra

Förderung

  • NCI NIH HHS

Zitieren

APA

Alban, J., Bowen, R. C., Reichstein, D. A., McKean, M., Lutzky, J., Weis, E., Carvajal, R. D., Dulka, S., Morse, B. G., Butler, M. O., Rapisuwon, S., Kim, K. B., Chandrasekaran, S., Warner, A. B., Zager, J. S., Chmielowski, B., Patel, S. P., Hernandez-Aya, L. F., Correa, Z. M., …, & Chandra, S. (2025). Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus. Cancers, 18(1), 121. https://doi.org/10.3390/cancers18010121

Vancouver

Alban J, Bowen RC, Reichstein DA, McKean M, Lutzky J, Weis E, et al. Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus. Cancers. 2025;18(1):121. doi:10.3390/cancers18010121

BibTeX
@article{Alban2025,
  author = {Alban, Juan and Bowen, R Christopher and Reichstein, David A and McKean, Meredith and Lutzky, Jose and Weis, Ezekiel and Carvajal, Richard D and Dulka, Susan and Morse, Brian G and Butler, Marcus O and Rapisuwon, Suthee and Kim, Kevin B and Chandrasekaran, Sanjay and Warner, Allison Betof and Zager, Jonathan S and Chmielowski, Bartosz and Patel, Sapna P and Hernandez-Aya, Leonel Fernando and Correa, Zelia M and Fecher, Leslie A and Najjar, Yana G and Montazeri, Kamaneh and Shoushtari, Alexander N and Javed, Asad and Gombos, Dan S and Salama, April K S and Tsai, Katy and Miller, Frank H and Khushalani, Nikhil and Seedor, Rino S and Lipson, Evan J and Reddy, Sunil A and Buchbinder, Elizabeth and Bhatia, Shailender and Pavlick, Anna and Mehmi, Inderjit and Aaberg, Thomas and Ikeguchi, Alexandra P and Kim, Ivana K and Walter, Scott D and Singh, Arun D and Sullivan, Ryan J and Choi, Jacob S and Williams, Basil K and Orloff, Marlana and Mruthyunjaya, Prithvi and Schollenberger, Megan D and Gandhi, Namita and Harbour, J William and Chandra, Sunandana},
  title = {Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus},
  journal = {Cancers},
  year = {2025},
  volume = {18},
  number = {1},
  pages = {121},
  doi = {10.3390/cancers18010121}
}
Kostenlos starten →